Skin & Soft Tissue Diseases

>

Latest News

WHO Enhances Mpox Diagnostics as Emergent BioSolutions’ Vaccine Receives Expanded Approval
WHO Enhances Mpox Diagnostics as Emergent BioSolutions’ Vaccine Receives Expanded Approval

September 3rd 2024

As the WHO seeks Emergency Use Listing for new diagnostics due to rising cases in the Democratic Republic of the Congo, 50,000 doses of this vaccine will be donated to Central Africa.

Trial of Skin Antisepsis in Surgery Could Double Antiseptics Recommended by WHO
Trial of Skin Antisepsis in Surgery Could Double Antiseptics Recommended by WHO

September 2nd 2024

Antibiotics Ranked by Risk for Serious Cutaneous Adverse Reactions
Antibiotics Ranked by Risk for Serious Cutaneous Adverse Reactions

September 1st 2024

HIV and Mpox: Risks, Prevention, and Vaccine Access
HIV and Mpox: Risks, Prevention, and Vaccine Access

August 20th 2024

Mpox Vaccine Manufacturer is Prepared to Increase Production
Mpox Vaccine Manufacturer is Prepared to Increase Production

August 19th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.